Adaptive Biotechnologies Corp Insider Sells 124,998 Shares

Chad Robins, CEO and Chairman of Adaptive Biotechnologies Corp (ADPT), sold 124,998 shares of the company on February 2, 2023. Following this transaction, Robins now owns 2,459,245 shares. This sale is part of a larger trend of insider selling, with 35 insider sales over the past year. The stock is currently trading at $18.44 and has a market cap of $2.641 billion. The price-to-GF-Value ratio is 2.15, indicating that the stock is overvalued based on its GF Value.